Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K1 in Spontaneous Intracerebral Hemorrhage
NCT03388970Phase 1Unknown
- Start
- Aug 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised trial of phytomenadione in intracerebral hemorrhage (ICH) (2 arms). Primary endpoint: Volume of cerebral hemorrhage at Day 7. Status: unknown.
02
Drugs
phytomenadione
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03388970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388970.